Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle S Cha

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|January 27, 2018
Determinants of cognitive function in individuals with type 2 diabetes mellitus: A meta-analysisRodrigo B Mansur, Yena Lee, Aileen J Zhou, et al.
Journal of Affective Disorders|June 11, 2018
Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive DisorderDanielle S Cha, Nicole E Carmona, Nelson B Rodrigues, et al.
Scandinavian Journal of Pain|August 30, 2017
Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it)Danielle S Cha, Nicole E Carmona, Rodrigo B Mansur, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 8, 2020
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of ExcellenceOrly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Psychiatry Research|November 19, 2021
Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effectsTuyen T Le, Joshua D Di Vincenzo, Kayla M Teopiz, et al.
The Journal of Clinical Psychiatry|September 1, 2017
The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive DisorderRoger S McIntyre, Michael W Best, Christopher R Bowie, et al.
CNS & Neurological Disorders Drug Targets|December 4, 2014
The putative impact of metabolic health on default mode network activity and functional connectivity in neuropsychiatric disordersDanielle S Cha, Francesco De Michele, Joanna K Soczynska, et al.
Obesity Research & Clinical Practice|October 29, 2015
Binge eating in adults with mood disorders: Results from the International Mood Disorders Collaborative ProjectHanna O Woldeyohannes, Joanna K Soczynska, Nadia A Maruschak, et al.
CNS Spectrums|December 31, 2015
Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative ProjectRoger S McIntyre, Hanna O Woldeyohannes, Joanna K Soczynska, et al.
Expert Opinion on Pharmacotherapy|January 2, 2024
The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysisDanielle S Cha, Nicholas Kleine, Kayla M Teopiz, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|January 27, 2018
Determinants of cognitive function in individuals with type 2 diabetes mellitus: A meta-analysisRodrigo B Mansur, Yena Lee, Aileen J Zhou, et al.
Journal of Affective Disorders|June 11, 2018
Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive DisorderDanielle S Cha, Nicole E Carmona, Nelson B Rodrigues, et al.
Scandinavian Journal of Pain|August 30, 2017
Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it)Danielle S Cha, Nicole E Carmona, Rodrigo B Mansur, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 8, 2020
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of ExcellenceOrly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Psychiatry Research|November 19, 2021
Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effectsTuyen T Le, Joshua D Di Vincenzo, Kayla M Teopiz, et al.
The Journal of Clinical Psychiatry|September 1, 2017
The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive DisorderRoger S McIntyre, Michael W Best, Christopher R Bowie, et al.
CNS & Neurological Disorders Drug Targets|December 4, 2014
The putative impact of metabolic health on default mode network activity and functional connectivity in neuropsychiatric disordersDanielle S Cha, Francesco De Michele, Joanna K Soczynska, et al.
Obesity Research & Clinical Practice|October 29, 2015
Binge eating in adults with mood disorders: Results from the International Mood Disorders Collaborative ProjectHanna O Woldeyohannes, Joanna K Soczynska, Nadia A Maruschak, et al.
CNS Spectrums|December 31, 2015
Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative ProjectRoger S McIntyre, Hanna O Woldeyohannes, Joanna K Soczynska, et al.
Expert Opinion on Pharmacotherapy|January 2, 2024
The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysisDanielle S Cha, Nicholas Kleine, Kayla M Teopiz, et al.
Pageof 8